Unknown

Dataset Information

0

Characterization of Chicken IgY Specific to Clostridium difficile R20291 Spores and the Effect of Oral Administration in Mouse Models of Initiation and Recurrent Disease.


ABSTRACT: Clostridium difficile infection (CDI) are the leading cause of world-wide nosocomial acquired diarrhea. The current main clinical challenge in CDI is the elevated rate of infection recurrence that may reach up to 30% of the patients, which has been associated to the formation of dormant spores during the infection. We sought to characterize the effects of oral administration of specific anti-spore IgY in mouse models of CDI and recurrent CDI. The specificity of anti-spore IgY was evaluated in vitro. In both, initiation mouse model and recurrence mouse model, we evaluated the prophylactic and therapeutic effect of anti-spore IgY, respectively. Our results demonstrate that anti-spore IgY exhibited high specificity and titers against C. difficile spores and reduced spore adherence to intestinal cells in vitro. Administration of anti-spore IgY to C57BL/6 mice prior and during CDI delayed the appearance of the diarrhea by 1.5 day, and spore adherence to the colonic mucosa by 90%. Notably, in the recurrence model, co-administration of anti-spore IgY coupled with vancomycin delayed the appearance of recurrent diarrhea by a median of 2 days. Collectively, these observations suggest that anti-spore IgY antibodies may be used as a novel prophylactic treatment for CDI, or in combination with antibiotics to treat CDI and prevent recurrence of the infection.

SUBMITTER: Pizarro-Guajardo M 

PROVIDER: S-EPMC5557795 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Characterization of Chicken IgY Specific to <i>Clostridium difficile</i> R20291 Spores and the Effect of Oral Administration in Mouse Models of Initiation and Recurrent Disease.

Pizarro-Guajardo Marjorie M   Díaz-González Fernando F   Álvarez-Lobos Manuel M   Paredes-Sabja Daniel D  

Frontiers in cellular and infection microbiology 20170814


<i>Clostridium difficile</i> infection (CDI) are the leading cause of world-wide nosocomial acquired diarrhea. The current main clinical challenge in CDI is the elevated rate of infection recurrence that may reach up to 30% of the patients, which has been associated to the formation of dormant spores during the infection. We sought to characterize the effects of oral administration of specific anti-spore IgY in mouse models of CDI and recurrent CDI. The specificity of anti-spore IgY was evaluate  ...[more]

Similar Datasets

| S-EPMC5226375 | biostudies-literature
| S-EPMC9986864 | biostudies-literature
| S-EPMC6370038 | biostudies-literature
| S-EPMC5031699 | biostudies-literature
| S-EPMC3758320 | biostudies-literature
| S-EPMC5311115 | biostudies-literature
| S-EPMC4442717 | biostudies-other
| S-EPMC7343902 | biostudies-literature
| S-EPMC2725610 | biostudies-literature
| S-EPMC5509370 | biostudies-literature